Activities and time-kill studies of selected penicillins, β-lactamase inhibitor combinations, and glycopeptides against Enterococcus faecalis

被引:14
作者
Hoellman, DB
Visalli, MA
Jacobs, MR
Appelbaum, PC
机构
[1] Penn State Univ, Milton S Hershey Med Ctr, Dept Pathol Clin Microbiol, Hershey, PA 17033 USA
[2] Case Western Reserve Univ, Dept Pathol Clin Microbiol, Cleveland, OH 44106 USA
关键词
D O I
10.1128/AAC.42.4.857
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
The activities of piperacillin, piperacillin-tazobactam, ticarcillin, ticarcillin-clavulanate, ampicillin, ampicillin-sulbactam, vancomycin, and teicoplanin were tested against 212 Enterococcus faecalis strains (9 beta-lactamase producers) by standard agar dilution MIC testing (10(4) CFU/spot). The MICs at which 50 and 90% of the isolates were inhibited (MIC(50)s and MIC(90)s, respectively) were as follows (mu g/ml): piperacillin, 4 and 8; piperacillin-tazobactam, 4 and 8; ticarcillin, 64 and 128; ticarcillin-clavulanate, 64 and 128; ampicillin, 2 and 2; ampicillin-sulbactam, 1 and 2; vancomycin, 1 and 4; and teicoplanin, 0.5 and 1. Agar dilution MIC testing of the nine beta-lactamase-positive strains with an inoculum of 10(6) CFU/spot revealed higher beta-lactam MICs (piperacillin, 64 to >256 mu g/ml; ticarcillin, 128 to >256 mu g/ml; and ampicillin, 16 to 128 mu g/ml); however, MICs with the addition of inhibitors were similar to those obtained with the lower inoculum. Time-kill studies of 15 strains showed that piperacillin-tazobactam was bactericidal (99.9% killing) for 14 strains after 24 h at four times the MIC, with 90% killing of all 15 strains at two times the MIC. After 12 and 6 h, 90% killing of 14 and 13 strains, respectively, was found at two times the MIC. Ampicillin gave 99.9% killing of 14 beta-lactamase-negative strains after 24 h at eight times the MIC, with 90% killing of all 15 strains at two times the MIC. After 12 and 6 h, 90% killing of 14 and 13 strains, respectively, was found at two times the MIC. Killing by ticarcillin-clavulanate was slower than that observed for piperacillin-tazobactam, relative to the MIC. For the one beta-lactamase-producing strain tested by time-kill analysis with a higher inoculum, addition of the three inhibitors (including sulbactam) to each of the beta-lactams resulted in bactericidal activity at 24 h at two times the MIC. For an enzyme-negative strain, addition of inhibitors did not influence kinetics. Kinetics of vancomycin and teicoplanin were significantly slower than those of the beta-lactams, with bactericidal activity against 6 strains after 24 h at eight times the MIC, with 90% killing of 12 and 14 strains, respectively, at four times the MIC. Slower-kill kinetics by both glycopeptides were observed at earlier periods.
引用
收藏
页码:857 / 861
页数:5
相关论文
共 21 条
[1]   GENETICS AND MECHANISMS OF GLYCOPEPTIDE RESISTANCE IN ENTEROCOCCI [J].
ARTHUR, M ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1993, 37 (08) :1563-1571
[2]   NATIONAL SURVEY OF THE IN-VITRO SPECTRUM OF PIPERACILLIN-TAZOBACTAM TESTED AGAINST MORE THAN 40,000 AEROBIC CLINICAL ISOLATES FROM 236 MEDICAL-CENTERS [J].
BARON, EJ ;
JONES, RN .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1995, 21 (03) :141-151
[3]   HIGH-LEVEL RESISTANCE TO AMINOGLYCOSIDES - COMPARISON OF COMMUNITY AND NOSOCOMIAL FECAL ISOLATES OF ENTEROCOCCI [J].
COQUE, TM ;
ARDUINO, RC ;
MURRAY, BE .
CLINICAL INFECTIOUS DISEASES, 1995, 20 (04) :1048-1051
[4]   RESISTANCE OF ENTEROCOCCI TO GLYCOPEPTIDES [J].
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1990, 34 (12) :2291-2296
[5]   INCREASING PROBLEMS IN THE THERAPY OF ENTEROCOCCAL INFECTIONS [J].
ELIOPOULOS, GM .
EUROPEAN JOURNAL OF CLINICAL MICROBIOLOGY & INFECTIOUS DISEASES, 1993, 12 (06) :409-412
[6]   ANTIMICROBIAL SUSCEPTIBILITY PATTERNS OF COMMON AND UNUSUAL SPECIES OF ENTEROCOCCI CAUSING INFECTIONS IN THE UNITED-STATES [J].
GORDON, S ;
SWENSON, JM ;
HILL, BC ;
PIGOTT, NE ;
FACKLAM, RR ;
COOKSEY, RC ;
THORNSBERRY, C ;
JARVIS, WR ;
TENOVER, FC .
JOURNAL OF CLINICAL MICROBIOLOGY, 1992, 30 (09) :2373-2378
[7]   ANTIBIOTIC-RESISTANCE IN ENTEROCOCCI [J].
GREENWOOD, D .
JOURNAL OF ANTIMICROBIAL CHEMOTHERAPY, 1989, 24 (05) :631-635
[8]   PIPERACILLIN TAZOBACTAM (YTR-830) COMBINATION - COMPARATIVE ANTIMICROBIAL ACTIVITY AGAINST 5889 RECENT AEROBIC CLINICAL ISOLATES AND 60 BACTEROIDES-FRAGILIS GROUP STRAINS [J].
JONES, RN ;
PFALLER, MA ;
FUCHS, PC ;
ALDRIDGE, K ;
ALLEN, SD ;
GERLACH, EH .
DIAGNOSTIC MICROBIOLOGY AND INFECTIOUS DISEASE, 1989, 12 (06) :489-494
[9]   Comparison of the bactericidal activities of piperacillin-tazobactam, ticarcillin-clavulanate, and ampicillin-sulbactam against clinical isolates of Bacteroides fragilis, Enterococcus faecalis, Escherichia coli, and Pseudomonas aeruginosa [J].
Klepser, ME ;
Marangos, MN ;
Zhu, Z ;
Nicolau, DP ;
Quintiliani, R ;
Nightingale, CH .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1997, 41 (02) :435-439
[10]   VANCOMYCIN RESISTANCE GENE VANC IS SPECIFIC TO ENTEROCOCCUS-GALLINARUM [J].
LECLERCQ, R ;
DUTKAMALEN, S ;
DUVAL, J ;
COURVALIN, P .
ANTIMICROBIAL AGENTS AND CHEMOTHERAPY, 1992, 36 (09) :2005-2008